Hear from thought leaders as they discuss their experiences in delivering NGS genomic profiles in just 1 day

Browse on-demand videos and presentations from our two symposia at ECP 2021.

Complete the form below to hear the latest news from thought leaders at ECP 2021 as they discussed how to easily implement next generation sequencing (NGS) for emerging biomarker detection with the same speed and simplicity of an IHC workflow.

Current and emerging oncology biomarkers testing strategies

In this seminar thought leaders will share their experience in delivering NGS genomic profiles in 1 day with the speed and simplicity of immunohistochemistry and how they have maximised their oncology biomarkers testing strategies to analyse current and emerging biomarkers.

Speakers:

Dr. Jon Sherlock
The future of precision oncology with 1-day NGS
Dr. Jon Sherlock, Director Product Management, Thermo Fisher Scientific
Dr. Javier Hernandez Losa
The economic advantage of 1-day NGS
Dr. Javier Hernandez Losa, Director of Molecular Biology Laboratory, Pathology Department, Vall d'Hebron University Hospital, Barcelona, Spain
Dr. Nicola Normanno
The role of comprehensive genomic profiling in emerging biomarker testing
Dr. Nicola Normanno, Director of Department of Experimental Oncology, INT-Fondazione Pascale, Naples, Italy
Prof. Dr. Peter Wild
Algorithms to use different sizes of panels for different types of cancer samples - experience in a molecular pathology lab
Prof. Dr. Peter Wild, Director of Dr. Senckenberg Institute for Pathology, University Hospital Frankfurt, Frankfurt, Germany

Comprehensive genomic profiling in precision oncology

In this symposium, you will hear about the experience of different laboratories and the strategy they are employing for different biomarker types and clinical research projects.

Speakers:

Dr. Jose Luis Costa
Introduction to multi-biomarker profiling: what is the data saying about it?
Dr. Jose Luis Costa, EMEA Medical Affairs Director, Thermo Fisher Scientific
Ilaria Alborelli, PhD
Comprehensive genomic profiling with the Oncomine Comprehensive Assay Plus
Ilaria Alborelli, PhD, Clinical Data Analyst, Institute of Pathology and Medical Genetics, University Hospital Basel, Switzerland
Dr. Massimo Barberis
Multicentric study to evaluate in-house solution for CGP
Dr. Massimo Barberis, Director of Histopathology and Molecular Diagnostics Unit, European Institute of Oncology, Milan, Italy

Watch or download the symposium presentations.

(*Indicates a mandatory field)

For Research Use Only. Not for use in diagnostic procedures.